These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9595452)

  • 1. Structure-activity analysis of C-terminal endothelin analogues.
    Rovero P; Galoppini C; Laricchia-Robbio L; Mazzoni MR; Revoltella RP
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S251-4. PubMed ID: 9595452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A structure-activity study of a C-terminal endothelin analogue.
    Cassano E; Galoppini C; Giusti L; Hamdan M; Macchia M; Mazzoni MR; Menchini E; Pegoraro S; Rovero P
    Folia Biol (Praha); 1998; 44(1):11-4. PubMed ID: 10730869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward the rational development of peptidomimetic analogs of the C-terminal endothelin hexapeptide: development of a theoretical model.
    Macchia M; Barontini S; Ceccarelli F; Galoppini C; Giusti L; Hamdan M; Lucacchini A; Martinelli A; Menchini E; Mazzoni MR; Revoltella RP; Romagnoli F; Rovero P
    Farmaco; 1998; 53(8-9):545-56. PubMed ID: 10081817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of the potent combined endothelin-A/endothelin-B receptor antagonist Ac-DDip16-Leu-Asp-Ile-Ile-Trp21: development of endothelin-B receptor selective antagonists.
    Cody WL; He JX; DePue PL; Waite LA; Leonard DM; Sefler AM; Kaltenbronn JS; Haleen SJ; Walker DM; Flynn MA
    J Med Chem; 1995 Jul; 38(15):2809-19. PubMed ID: 7636842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor binding and biologic activity of synthetic ET-1 peptides in the retinal pericyte.
    McDonald DM; Bailie JR; Archer DB; Chakravarthy U
    Invest Ophthalmol Vis Sci; 1996 May; 37(6):1067-73. PubMed ID: 8631622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and epitope mapping of immunoreactive human endothelin-1 using ELISA and a surface plasmon resonance-based biosensor.
    Laricchia-Robbio L; Moscato S; Guidi A; Viganò S; Rovero P; Revoltella RP
    Biosens Bioelectron; 1997; 12(8):765-78. PubMed ID: 9421886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of a potent combined pseudopeptide endothelin-A/endothelin-B receptor antagonist, Ac-DBhg16-Leu-Asp-Ile-[NMe]Ile-Trp21 (PD 156252): examination of its pharmacokinetic and spectral properties.
    Cody WL; He JX; Reily MD; Haleen SJ; Walker DM; Reyner EL; Stewart BH; Doherty AM
    J Med Chem; 1997 Jul; 40(14):2228-40. PubMed ID: 9216842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspartate mutation distinguishes ETA but not ETB receptor subtype-selective ligand binding while abolishing phospholipase C activation in both receptors.
    Rose PM; Krystek SR; Patel PS; Liu EC; Lynch JS; Lach DA; Fisher SM; Webb ML
    FEBS Lett; 1995 Mar; 361(2-3):243-9. PubMed ID: 7698331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rabbit antiserum raised against the hexapeptide endothelin(16-21) shows different binding affinities for endothelin-1, -2 and -3.
    Löffler BM; Jacot-Guillarmod H
    Life Sci; 1992; 50(25):2001-9. PubMed ID: 1593928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationship for ETB agonism in truncated endothelin-1 analogs.
    Saeki T; Ihara M; Fukuroda T; Yano M
    Biochem Int; 1992 Oct; 28(2):305-12. PubMed ID: 1456952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Truncated analogues of endothelin and sarafotoxin are selective for the ETB receptor subtype.
    Heyl DL; Cody WL; He JX; Flynn MA; Welch KM; Reynolds EE; Doherty AM
    Pept Res; 1993; 6(5):238-41. PubMed ID: 8257799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alanine scan of endothelin: importance of aromatic residues.
    Tam JP; Liu W; Zhang JW; Galantino M; Bertolero F; Cristiani C; Vaghi F; de Castiglione R
    Peptides; 1994; 15(4):703-8. PubMed ID: 7937349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of endothelin A (ETA) and endothelin B (ETB) receptors in cultured bovine retinal pericytes.
    McDonald DM; Bailie JR; Archer DB; Chakravarthy U
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):1088-94. PubMed ID: 7730018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand binding domain of the human endothelin-B subtype receptor.
    Wada K; Hashido K; Terashima H; Adachi M; Fujii Y; Hiraoka O; Furuichi Y; Miyamoto C
    Protein Expr Purif; 1995 Jun; 6(3):228-36. PubMed ID: 7663155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological and molecular analyses of structurally reduced analogues of endothelin-1.
    Forget MA; Lebel N; Sirois P; Boulanger Y; Fournier A
    Mol Pharmacol; 1996 Jun; 49(6):1071-9. PubMed ID: 8649345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-induced nociception in mice: mediation by ETA and ETB receptors.
    Raffa RB; Schupsky JJ; Jacoby HI
    J Pharmacol Exp Ther; 1996 Feb; 276(2):647-51. PubMed ID: 8632332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-1 analogues substituted at both position 18 and 19: highly potent endothelin antagonists with no selectivity for either receptor subtype ETA or ETB.
    Kikuchi T; Kubo K; Ohtaki T; Suzuki N; Asami T; Shimamoto N; Wakimasu M; Fujino M
    J Med Chem; 1993 Dec; 36(25):4087-93. PubMed ID: 8258832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin binding to NG108-15 cells: evidence for conventional ETA and ETB receptor subtypes and super-high affinity binding components.
    Angelova K; Ergul A; Narayan P; Puett D
    Cell Mol Biol (Noisy-le-grand); 1996 Dec; 42(8):1243-57. PubMed ID: 8997527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationship studies of new endothelin pseudopeptide analogues containing alkyl spacers.
    Galoppini C; Giusti L; Macchia M; Hamdan M; Mazzoni MR; Calvani F; Rovero P
    Farmaco; 1999 Apr; 54(4):213-7. PubMed ID: 10384713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of C-terminal endothelin hexapeptide antagonists.
    Doherty AM; Cody WL; DePue PL; He JX; Waite LA; Leonard DM; Leitz NL; Dudley DT; Rapundalo ST; Hingorani GP
    J Med Chem; 1993 Sep; 36(18):2585-94. PubMed ID: 8410970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.